Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
As your body becomes accustomed to the medication and you improve your hydration and eating habits, the dizziness usually subsides
Retatrutide has demonstrated up to 24% body weight reduction in clinical trials, which could significantly benefit PCOS-related metabolic dysfunction The medication's triple-action mechanism may address multiple PCOS symptoms simultaneously, including insulin resistance and appetite regulation Clinical trials are ongoing, with UK regulatory approval expected following successful completion of phase 3 studies Weight loss achieved through GLP-1 receptor agonists has been shown to improve menstrual regularity and reduce androgen levels in PCOS Women with PCOS should discuss emerging treatment options with their healthcare provider whilst monitoring developments in this area PCOS Symptom Tracker Track your symptoms to discuss with your healthcare provider Table of Contents Understanding PCOS and Why Weight Management Matters What Is Retatrutide and How Does It Work
How much weight can you lose on Wegovy HD
The primary mechanisms of action include: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner, which helps lower blood glucose levels without causing excessive hypoglycaemia Suppressing glucagon release from pancreatic alpha cells, reducing hepatic glucose production Slowing gastric emptying , which prolongs the feeling of fullness after meals Acting on appetite centres in the brain , particularly the hypothalamus, to reduce hunger and food intake Most GLP-1 receptor agonists are administered via subcutaneous injection, with dosing frequencies ranging from once daily to once weekly depending on the specific formulation
